Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A salivary protein panel for detecting malignant transformation of oral leukoplakia.

Oral oncology·2026
Same author

SRSF3 determines T<sub>reg</sub> cell fate in antitumor immunity and autoimmunity.

Science advances·2026
Same author

ATF4 promotes immune evasion in oral squamous cell carcinoma by suppressing autophagic PD-L1 degradation.

Journal for immunotherapy of cancer·2026
Same author

L-shaped iliac crest flap: an effective solution for reconstructing Class I and II mandibular defects - a retrospective study.

BMC oral health·2026
Same author

A Microchip-Based Gauge for Visual Prediction of Immunotherapy via Distance Readout of Microvesicles.

Analytical chemistry·2026
Same author

From Biomedical Mechanisms to Clinical Applications: Research Progress in Plant-Derived Vesicles for Cancer Therapy.

International journal of nanomedicine·2026

Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.2K

Predictive Analysis in Oral Cancer Immunotherapy: Profiling Dual PD-L1-Positive Extracellular Vesicle Subtypes with

Zi-Li Yu1,2, Zhou-Yang Wu1, Xing-Chi Liu1

  • 1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.

Analytical Chemistry
|September 5, 2024
PubMed
Summary

This study introduces a new microfluidic chip to distinguish between immune and tumor cell-derived PD-L1-positive extracellular vesicles (PD-L1+ EVs). This advancement aids in predicting oral cancer immunotherapy response using saliva-based liquid biopsies.

More Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.7K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

Area of Science:

  • Biomarker Discovery
  • Cancer Research
  • Microfluidics

Background:

  • PD-L1-positive extracellular vesicles (PD-L1+ EVs) are crucial predictive biomarkers in cancer immunotherapy.
  • Distinguishing between immune (I-PD-L1+ EVs) and tumor (T-PD-L1+ EVs) cell-derived PD-L1+ EVs is vital for accurate liquid biopsy.
  • Existing methods like ELISA cannot differentiate the cellular origins of PD-L1+ EVs.

Purpose of the Study:

  • To develop a novel microfluidic chip for simultaneous quantification and differentiation of PD-L1+ EV subpopulations.
  • To analyze PD-L1+ EV subtypes in saliva for oral squamous cell carcinoma (OSCC) patients.
  • To correlate PD-L1+ EV levels with immunotherapy response in OSCC patients.

Main Methods:

  • Development of a step-wedge microfluidic chip integrating magnetic microsphere separation and fluorescence counting.
  • Use of anti-PD-L1 antibodies on magnetic microspheres and fluorescent nanoparticles targeting EpCAM (tumor marker) or CD45 (immune marker).
  • Simultaneous detection and quantification of I-PD-L1+ EVs and T-PD-L1+ EVs in saliva samples.

Main Results:

  • Reduced levels of I-PD-L1+ EVs were observed in OSCC patients compared to healthy individuals.
  • Immunotherapy responders showed decreased total PD-L1+ EVs, T-PD-L1+ EVs, and I-PD-L1+ EVs.
  • Non-responders exhibited increased levels of I-PD-L1+ EVs during immunotherapy.

Conclusions:

  • The novel microfluidic chip enables sensitive and simultaneous analysis of PD-L1+ EV subtypes.
  • Salivary PD-L1+ EV subtyping can differentiate between cancer patients and healthy individuals.
  • This method facilitates precise prediction of oral cancer immunotherapy outcomes based on EV profiles.